Co-trimoxazole reduces mortality in anti-MDA5-DM

Nature Reviews Rheumatology, Published online: 10 March 2023; doi:10.1038/s41584-023-00939-zResults indicate that prophylactic use of co-trimoxazole can reduce infection-related mortality in patients with new-onset anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis.

https://www.nature.com/articles/s41584-023-00939-z

Source: Nature Reviews Rheumatology - March 10, 2023 Category: Rheumatology Authors: Robert Phillips Source Type: research